98 related articles for article (PubMed ID: 21703973)
1. Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study.
Elad S; Zeevi I; Finke J; Koldehoff M; Schwerdtfeger R; Wolff D; Mohrbacher R; Levitt M; Greinwald R; Shapira MY
Biol Blood Marrow Transplant; 2012 Jan; 18(1):134-40. PubMed ID: 21703973
[TBL] [Abstract][Full Text] [Related]
2. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.
Dilger K; Halter J; Bertz H; Lopez-Lazaro L; Gratwohl A; Finke J
Biol Blood Marrow Transplant; 2009 Mar; 15(3):336-43. PubMed ID: 19203724
[TBL] [Abstract][Full Text] [Related]
4. Formulation of budesonide mouthwash for the treatment of oral chronic graft-versus-host disease.
Van Schandevyl G; Bauters T
J Oncol Pharm Pract; 2016 Feb; 22(1):82-5. PubMed ID: 25411262
[TBL] [Abstract][Full Text] [Related]
5. Budesonide: a novel treatment for oral chronic graft versus host disease.
Elad S; Or R; Garfunkel AA; Shapira MY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
[TBL] [Abstract][Full Text] [Related]
6. Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide.
Zadik Y; Elad S; Shapira A; Shapira MY
Expert Opin Pharmacother; 2017 Feb; 18(3):235-242. PubMed ID: 28081677
[TBL] [Abstract][Full Text] [Related]
7. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease.
Park AR; La HO; Cho BS; Kim SJ; Lee BK; Rhie JY; Gwak HS
Am J Health Syst Pharm; 2013 Aug; 70(16):1383-91. PubMed ID: 23903476
[TBL] [Abstract][Full Text] [Related]
8. A New Formulation of an Old Drug: A Potential New Therapy in the Management of Oral cGvHD.
Bertelli L; Di Nardo G; Zama D; Bardasi G; Morello W; Masetti R; Belotti T; Forchielli ML; Prete A; Pession A
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e295-e297. PubMed ID: 27299595
[TBL] [Abstract][Full Text] [Related]
9. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Holzhueter S; Loddenkemper C; Steiner B; Freund M; Wolff D
Bone Marrow Transplant; 2008 Oct; 42(8):541-6. PubMed ID: 18641680
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD.
Bertz H; Afting M; Kreisel W; Duffner U; Greinwald R; Finke J
Bone Marrow Transplant; 1999 Dec; 24(11):1185-9. PubMed ID: 10642806
[TBL] [Abstract][Full Text] [Related]
11. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
12. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.
Wolff D; Anders V; Corio R; Horn T; Morison WL; Farmer E; Vogelsang GB
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):184-90. PubMed ID: 15238096
[TBL] [Abstract][Full Text] [Related]
13. Topical Corticosteroids a Viable Solution for Oral Graft Versus Host Disease? A Systematic Insight on Randomized Clinical Trials.
Sava A; Piciu A; Pasca S; Mester A; Tomuleasa C
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32674447
[No Abstract] [Full Text] [Related]
14. An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease.
Treister N; Li S; Kim H; Lerman M; Sultan A; Alyea EP; Armand P; Cutler C; Ho V; Koreth J; Antin JH; Soiffer R
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2084-2091. PubMed ID: 27590106
[TBL] [Abstract][Full Text] [Related]
15. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Akpek G; Lee SM; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2001; 7(9):495-502. PubMed ID: 11669216
[TBL] [Abstract][Full Text] [Related]
16. Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD.
Mawardi H; Stevenson K; Gokani B; Soiffer R; Treister N
Bone Marrow Transplant; 2010 Jun; 45(6):1062-7. PubMed ID: 19881552
[TBL] [Abstract][Full Text] [Related]
17. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
Epstein JB; Reece DE
Bone Marrow Transplant; 1994 Jan; 13(1):81-6. PubMed ID: 8019458
[TBL] [Abstract][Full Text] [Related]
18. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
[TBL] [Abstract][Full Text] [Related]
19. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports.
Utsman RA; Epstein JB; Elad S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):e11-7. PubMed ID: 18585605
[TBL] [Abstract][Full Text] [Related]
20. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
Epstein JB; Gorsky M; Epstein MS; Nantel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
